A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

5 mg/kg intravenously administered on day 1 of a 2-week cycle.

2000mg/m2/day oral on day 1 to day 10 of a 2-week cycle.

180 mg/m2 intravenously administered on day 1 of a 2-week cycle.

400 mg/m2 intravenous bolus on day 1 and 2400 mg/m2 continuous infusion over 44 hours of a 2-week cycle.

300 mg/m2 intravenously administered on day 1 of a 2-week cycle.

150 mg/m2 intravenously administered on day 1 of a 2-week cycle.